McLeod LD, Mallya UG, Fox T, Zhao Y, Mordin MM, Strober B. Psoriasis patients with PASI90 response achieve greater health-related quality of life improvements than those with PASI75 response. Poster presented at the SDPA Annual Summer Dermatology Conference 2015; June 4, 2015. Las Vegas, NV. Previously presented at the 23rd European Academy of Dermatology and Venereology Congress.